AngioInsight
Michigan-based AngioInsight offers a fully automated platform for coronary angiogram video interpretation.
Founded
2018Michigan-based AngioInsight offers a fully automated platform for coronary angiogram video interpretation.
Founded in Ann Arbor, Michigan, AngioInsight is dedicated to transforming the care of coronary artery disease through advanced artificial intelligence and computational modeling. The company's core mission is to enable cardiologists to fully leverage anatomical and physiological diagnostics, thereby augmenting clinical decisions, improving patient outcomes, and reducing treatment costs. AngioInsight offers a fully automated platform for interpreting coronary angiogram videos with speed and accuracy, focusing on enhancing diagnostic precision in the cath lab.
Notable affiliated individuals include experts in cardiology and AI technology, although specific names are not provided. AngioInsight has achieved significant milestones in the healthcare tech industry by integrating AI into coronary artery disease diagnostics, leading to more accurate and timely clinical decisions. The company's impact is evident in its potential to improve patient outcomes and streamline costs in the treatment of coronary artery disease.
Companies similar to AngioInsight include InVision Medical Technology, Dyad Medical, Heartio and Cardio Diagnostics Holdings.
AngioInsight was founded in 2018.
AngioInsight's headquarters is located in Ann Arbor, MI, US.
AngioInsight's most recent funding round was for $256k (USD) in June 2022.
As of Jun 15, 2022, AngioInsight has disclosed funding of $256k (USD). Undisclosed round amounts are excluded.
AngioInsight has 5 employees as of Feb 4, 2024.
Cardio Diagnostics Holdings
